The safety of RhIG in the prevention of haemolytic disease of the newborn
- 1 January 2007
- journal article
- review article
- Published by Informa UK Limited in Journal of Obstetrics and Gynaecology
- Vol. 27 (6), 545-557
- https://doi.org/10.1080/01443610701469941
Abstract
(2007). The safety of RhIG in the prevention of haemolytic disease of the newborn. Journal of Obstetrics and Gynaecology: Vol. 27, No. 6, pp. 545-557.Keywords
This publication has 54 references indexed in Scilit:
- Pathogen inactivation and removal procedures used in the production of intravenous immunoglobulinsBiologicals, 2007
- Do we need to be more concerned about weak D antigens?Transfusion, 2005
- Ensuring the pathogen safety of intravenous immunoglobulin and other human plasma–derived therapeutic proteinsJournal of Allergy and Clinical Immunology, 2001
- Scrapie Removal using Planova®Virus Removal FiltersBiologicals, 2001
- Evaluation of the Safety of Rh Immunoglobulin by Monitoring Viral Markers among Rh-Negative Female Blood DonorsVox Sanguinis, 2000
- Transmission Rates of Hepatitis C Virus by Different Batches of a Contaminated Anti‐D Immunoglobulin PreparationVox Sanguinis, 1999
- A Second Outbreak of Hepatitis C Virus Infection from Anti‐D Immunoglobulin in IrelandVox Sanguinis, 1999
- Fetomaternal Transplacental Hemorrhage during Pregnancy and after DeliveryVox Sanguinis, 1986
- ROLE OF INDUCED ABORTION IN RHESUS IMMUNISATIONThe Lancet, 1971
- Erythroblastosis fetalis and its association with universal edema of the fetus, icterus gravis neonatorum and anemia of the newbornThe Journal of Pediatrics, 1932